![Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure](https://cdn.cancerletter.com/media/2024/01/01031934/40-45-power-morcellation.jpg)
![Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure](https://cdn.cancerletter.com/media/2024/01/01031934/40-45-power-morcellation.jpg)
Cover Story
Free
The power morcellator should no longer be used for hysterectomies or fibroid removal in the vast majority of women getting these procedures, FDA declared in a highly anticipated guidance document Nov. 24.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Better oncology drug management could lead to improved outcomes, lower costs
- Tweaking the existing systems is not the answer to drug shortages